Acromegaly
Acute octreotide test doesn't predict long-term Sandostatin LAR efficacy
Published in Medical Devices and Surgical Technology Week, September 4th, 2005
In a recent study, endocrinologists in the Netherlands sought to determine "whether the growth hormone (GH) response after the subcutaneous administration of 50 microg of octreotide (acute octreotide test) has any predictive value for long-term IGF-I normalization with Sandostatin LAR."
"Twenty four therapy-naive patients with active acromegaly were studied," noted W.W. de Herder and coauthors working at the Erasmus Medical Center. They found that a ">75% GH decrease in the acute octreotide test predicted long-term IGF-I normalization with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Bioinformatics
Web tools facilitate the design and optimization of RNAi constructs - Contraception
Dual birth control/disease protection method could reduce pregnancy risk - Cryotherapy
Women in Peru test cryotherapy treatment for cervical dysplasia - Echinococcosis
Ultrasound useful for cystic echinococcosis screening in Peru - Abdominal Trauma
Screening ultrasound useful in hypotensive patients - Ablation
Specially equipped electrodes may prevent burns during ablation - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
